ARCHIVES

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

April 15, 1977

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013

NCI awards $7.3 Million for Studies In Cancer communications

October 15, 1993

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

No Constitutional Right To Experimental Drugs, Appeals Court Rules Against Abigail Alliance.

August 10, 2007